stars 1 stars 2 stars 3

Catch Genes from Liquid Biopsy is what we are doing now. Founded in 2016, CatchGene Co., Ltd. groups experts from different fields, including molecular biology, electrical engineering, software engineering and mechanics. We are dedicating to develop a better solution for purifying rare cfDNA or cfRNA from Liquid Biopsy. Molecular diagnostic is a rapid developing field. With more and more biomarker, nowadays people are able to predict, diagnostic or tracing many diseases. Many people are focusing on how to increase the sensitivity of detection reagents or devices. But actually, the most important step is to catch DNA/RNA first. Because if we can’t catch those genes, even the detection method is extreme sensitive, we still can’t detect it. CatchGene is focusing on get higher quality of cfDNA, cfRNA or miRNA from Liquid Biopsy and DNA/RNA Solid Biopsy because we know that DNA/RNA purification is the first step of achieving “Precision Medicine”. Have a vision to overcome the bottle neck of Precision Medicine, we developed the iCATCHER system which able to purify cfDNA, miRNA from up to 4 ml Liquid Biopsy and extract high integrity DNA/RNA from FFPE tissue sample. Hope the solution will put some efforts on Cancer prediction, Cancer diagnostic and Cancer tracing. To makes a better life for human being.

CatchGene Questions

The CatchGene annual revenue was $200000 in 2026.

The NAICS codes for CatchGene are [54, 541, 5417, 541713, 54171].

The SIC codes for CatchGene are [873, 87].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users